Charles M Rowland

Title: Innovations of Charles M Rowland

Introduction

Charles M Rowland is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of genetics, particularly in relation to coronary heart disease and drug response. With a total of 6 patents, Rowland's work has the potential to impact medical treatments and patient outcomes.

Latest Patents

Rowland's latest patents focus on genetic polymorphisms associated with coronary events and drug response. These inventions provide compositions and methods based on genetic polymorphisms that are linked to coronary heart disease, specifically myocardial infarction and aneurysm/dissection. The patents detail nucleic acid molecules containing these polymorphisms, variant proteins encoded by these molecules, and reagents for their detection. Furthermore, the methods outlined in these patents aim to utilize these nucleic acid molecules and proteins effectively in medical applications.

Career Highlights

Charles M Rowland is currently associated with Celera Corporation, where he continues to advance his research and innovations. His work at Celera has positioned him as a key figure in the exploration of genetic factors influencing heart disease and treatment responses.

Collaborations

Rowland has collaborated with notable colleagues, including Olga Iakoubova and James J Devlin. These partnerships have contributed to the development and refinement of his innovative ideas and patents.

Conclusion

Charles M Rowland's contributions to the field of genetics and his innovative patents highlight the importance of research in understanding and treating coronary heart disease. His work continues to pave the way for advancements in medical science and patient care.